Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Labcorp to Speak at the Baird 2022 Global Healthcare Conference By: Labcorp via Business Wire September 06, 2022 at 06:59 AM EDT Labcorp (NYSE: LH), a leading global life sciences company, today announced that members of the executive management team will participate in a fireside chat at the Baird 2022 Global Healthcare Conference on Tuesday, Sept. 13, at 9:05 a.m. ET. A live webcast of the fireside chat will be available via the Labcorp Investor Relations website and archived for replay. About Labcorp Labcorp is a leading global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. Through our unparalleled diagnostics and drug development capabilities, we provide insights and accelerate innovations to improve health and improve lives. With over 75,000 employees, we serve clients in more than 100 countries. Labcorp (NYSE: LH) reported revenue of $16 billion in FY2021. Learn more about us at www.Labcorp.com or follow us on LinkedIn and Twitter @Labcorp. # # # View source version on businesswire.com: https://www.businesswire.com/news/home/20220905005458/en/Contacts Labcorp Contacts: Investors: Chas Cook — 336-436-5076 Investor@Labcorp.com Media: Christopher Allman-Bradshaw — 336-436-8263 Media@Labcorp.com Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Labcorp to Speak at the Baird 2022 Global Healthcare Conference By: Labcorp via Business Wire September 06, 2022 at 06:59 AM EDT Labcorp (NYSE: LH), a leading global life sciences company, today announced that members of the executive management team will participate in a fireside chat at the Baird 2022 Global Healthcare Conference on Tuesday, Sept. 13, at 9:05 a.m. ET. A live webcast of the fireside chat will be available via the Labcorp Investor Relations website and archived for replay. About Labcorp Labcorp is a leading global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. Through our unparalleled diagnostics and drug development capabilities, we provide insights and accelerate innovations to improve health and improve lives. With over 75,000 employees, we serve clients in more than 100 countries. Labcorp (NYSE: LH) reported revenue of $16 billion in FY2021. Learn more about us at www.Labcorp.com or follow us on LinkedIn and Twitter @Labcorp. # # # View source version on businesswire.com: https://www.businesswire.com/news/home/20220905005458/en/Contacts Labcorp Contacts: Investors: Chas Cook — 336-436-5076 Investor@Labcorp.com Media: Christopher Allman-Bradshaw — 336-436-8263 Media@Labcorp.com
Labcorp (NYSE: LH), a leading global life sciences company, today announced that members of the executive management team will participate in a fireside chat at the Baird 2022 Global Healthcare Conference on Tuesday, Sept. 13, at 9:05 a.m. ET. A live webcast of the fireside chat will be available via the Labcorp Investor Relations website and archived for replay. About Labcorp Labcorp is a leading global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. Through our unparalleled diagnostics and drug development capabilities, we provide insights and accelerate innovations to improve health and improve lives. With over 75,000 employees, we serve clients in more than 100 countries. Labcorp (NYSE: LH) reported revenue of $16 billion in FY2021. Learn more about us at www.Labcorp.com or follow us on LinkedIn and Twitter @Labcorp. # # # View source version on businesswire.com: https://www.businesswire.com/news/home/20220905005458/en/
Labcorp Contacts: Investors: Chas Cook — 336-436-5076 Investor@Labcorp.com Media: Christopher Allman-Bradshaw — 336-436-8263 Media@Labcorp.com